China SXT Pharmaceuticals (SXTC) Competitors $1.58 -0.03 (-1.86%) Closing price 08/14/2025 04:00 PM EasternExtended Trading$1.62 +0.04 (+2.85%) As of 08/14/2025 06:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock SXTC vs. SION, NAGE, TNGX, MNMD, STOK, ANAB, VIR, AMLX, GHRS, and DNTHShould you be buying China SXT Pharmaceuticals stock or one of its competitors? The main competitors of China SXT Pharmaceuticals include Sionna Therapeutics (SION), Niagen Bioscience (NAGE), Tango Therapeutics (TNGX), Mind Medicine (MindMed) (MNMD), Stoke Therapeutics (STOK), AnaptysBio (ANAB), Vir Biotechnology (VIR), Amylyx Pharmaceuticals (AMLX), GH Research (GHRS), and Dianthus Therapeutics (DNTH). These companies are all part of the "pharmaceutical products" industry. China SXT Pharmaceuticals vs. Its Competitors Sionna Therapeutics Niagen Bioscience Tango Therapeutics Mind Medicine (MindMed) Stoke Therapeutics AnaptysBio Vir Biotechnology Amylyx Pharmaceuticals GH Research Dianthus Therapeutics China SXT Pharmaceuticals (NASDAQ:SXTC) and Sionna Therapeutics (NASDAQ:SION) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, media sentiment, risk, earnings, analyst recommendations, dividends, institutional ownership and profitability. Do analysts rate SXTC or SION? Sionna Therapeutics has a consensus target price of $38.50, indicating a potential upside of 84.12%. Given Sionna Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Sionna Therapeutics is more favorable than China SXT Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score China SXT Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Sionna Therapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is SXTC or SION more profitable? Company Net Margins Return on Equity Return on Assets China SXT PharmaceuticalsN/A N/A N/A Sionna Therapeutics N/A N/A N/A Do institutionals & insiders hold more shares of SXTC or SION? 5.0% of China SXT Pharmaceuticals shares are held by institutional investors. 4.0% of China SXT Pharmaceuticals shares are held by insiders. Comparatively, 3.9% of Sionna Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the media prefer SXTC or SION? In the previous week, Sionna Therapeutics had 7 more articles in the media than China SXT Pharmaceuticals. MarketBeat recorded 9 mentions for Sionna Therapeutics and 2 mentions for China SXT Pharmaceuticals. Sionna Therapeutics' average media sentiment score of 1.08 beat China SXT Pharmaceuticals' score of 0.43 indicating that Sionna Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment China SXT Pharmaceuticals Neutral Sionna Therapeutics Positive Which has stronger earnings & valuation, SXTC or SION? China SXT Pharmaceuticals has higher revenue and earnings than Sionna Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioChina SXT Pharmaceuticals$1.74M105.36-$3.30MN/AN/ASionna TherapeuticsN/AN/A-$61.69MN/AN/A SummarySionna Therapeutics beats China SXT Pharmaceuticals on 5 of the 9 factors compared between the two stocks. Get China SXT Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SXTC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SXTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SXTC vs. The Competition Export to ExcelMetricChina SXT PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$186.80M$2.48B$5.61B$9.84BDividend YieldN/A1.76%4.61%4.07%P/E RatioN/A22.0530.2825.74Price / Sales105.36742.42460.47115.79Price / CashN/A184.4138.2159.48Price / Book0.074.838.856.15Net Income-$3.30M$31.61M$3.25B$265.06M7 Day Performance1.22%4.55%3.72%2.60%1 Month Performance-5.28%5.69%5.86%2.83%1 Year Performance-80.83%12.71%30.34%25.58% China SXT Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SXTCChina SXT Pharmaceuticals0.4031 of 5 stars$1.58-1.9%N/A-80.8%$186.80M$1.74M0.0090Short Interest ↑SIONSionna Therapeutics2.1325 of 5 stars$17.12+1.2%$38.50+124.9%N/A$755.33MN/A0.0035Earnings ReportNAGENiagen Bioscience1.3699 of 5 stars$9.37-2.8%$13.22+41.1%N/A$738.08M$99.60M55.12120Analyst RevisionTNGXTango Therapeutics1.9473 of 5 stars$6.80+3.2%$10.50+54.4%-25.6%$737.73M$40.99M-5.5890News CoveragePositive NewsAnalyst RevisionGap DownMNMDMind Medicine (MindMed)2.7204 of 5 stars$9.59+2.4%$24.71+157.8%+46.1%$725.13MN/A-6.2740STOKStoke Therapeutics4.1339 of 5 stars$13.11-0.3%$25.80+96.9%+22.9%$715.32M$36.56M16.58100Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionGap DownANABAnaptysBio3.1395 of 5 stars$24.19-0.2%$47.13+94.8%-42.4%$710.79M$91.28M-4.99100Analyst ForecastGap DownVIRVir Biotechnology3.2047 of 5 stars$5.08-0.5%$30.25+496.1%-47.1%$703.78M$74.21M-1.21580Gap DownAMLXAmylyx Pharmaceuticals3.3552 of 5 stars$7.92-0.5%$11.75+48.4%+294.8%$702.97M-$1.27M-2.54200GHRSGH Research3.0588 of 5 stars$13.46+0.2%$32.00+137.7%+29.8%$700.84MN/A-17.0510News CoveragePositive NewsAnalyst RevisionDNTHDianthus Therapeutics1.1865 of 5 stars$21.39+3.9%$53.00+147.8%-28.9%$692.41M$6.24M-7.4880News CoverageAnalyst Revision Related Companies and Tools Related Companies Sionna Therapeutics Alternatives Niagen Bioscience Alternatives Tango Therapeutics Alternatives Mind Medicine (MindMed) Alternatives Stoke Therapeutics Alternatives AnaptysBio Alternatives Vir Biotechnology Alternatives Amylyx Pharmaceuticals Alternatives GH Research Alternatives Dianthus Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SXTC) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China SXT Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share China SXT Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access